We are live on ! Find out more
N

Nuveen Portfolio holdings

AUM $369B
1-Year Est. Return 31.66%
This Fund
S&P 500
This Quarter Est. Return
+10.52%
1 Year Est. Return
+31.66%
3 Year Est. Return
+110.02%
5 Year Est. Return
+148.02%
10 Year Est. Return
+492.84%
AUM
$287B
AUM Growth
+$18.5B
Cap. Flow
-$4.92B
Cap. Flow %
-1.71%
Top 10 Hldgs %
26.06%
Holding
3,383
New
280
Increased
1,384
Reduced
1,249
Closed
179

Top Buys

Rank Stock Value
1
AMZN icon
Amazon
AMZN
+$672M
2
AMAT icon
Applied Materials
AMAT
+$241M
3
KVUE icon
Kenvue
KVUE
+$220M
4
CRM icon
Salesforce
CRM
+$210M
5
PYPL icon
PayPal
PYPL
+$195M

Sector Composition

Rank Sector Weight
1 Technology 27.88%
2 Healthcare 12.64%
3 Financials 11.25%
4 Consumer Discretionary 11%
5 Industrials 8.78%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
QCOM icon
101
Qualcomm
QCOM
$174B
$572M 0.2%
4,801,002
-124,961
-3% -$14.4M
BLK icon
102
Blackrock
BLK
$175B
$559M 0.19%
808,496
-12,734
-2% -$8.53M
AMP icon
103
Ameriprise Financial
AMP
$48.7B
$556M 0.19%
1,673,748
+382,811
+30% +$118M
ROP icon
104
Roper Technologies
ROP
$39.6B
$554M 0.19%
1,151,511
+239,623
+26% +$109M
DD icon
105
DuPont de Nemours
DD
$19.6B
$550M 0.19%
6,137,955
+1,004,619
+20% +$86.4M
TT icon
106
Trane Technologies
TT
$106B
$547M 0.19%
2,859,968
-57,882
-2% -$10.3M
MDT icon
107
Medtronic
MDT
$110B
$541M 0.19%
6,143,623
+48,774
+0.8% +$4.2M
AEP icon
108
American Electric Power
AEP
$68.6B
$522M 0.18%
6,203,730
-293,760
-5% -$25.9M
IBM icon
109
IBM
IBM
$222B
$519M 0.18%
3,881,103
+290,732
+8% +$37.5M
EL icon
110
Estee Lauder
EL
$31.6B
$519M 0.18%
2,643,157
+8,469
+0.3% +$1.8M
MSI icon
111
Motorola Solutions
MSI
$77.6B
$516M 0.18%
1,759,412
-65,617
-4% -$18.8M
SPG icon
112
Simon Property Group
SPG
$72.2B
$509M 0.18%
4,410,455
-9,141
-0.2% -$996K
SYK icon
113
Stryker
SYK
$129B
$506M 0.18%
1,658,717
+3,875
+0.2% +$1.12M
BSX icon
114
Boston Scientific
BSX
$71.8B
$506M 0.18%
9,353,939
+1,323,650
+16% +$69.1M
PXD
115
DELISTED
Pioneer Natural Resource Co.
PXD
$496M 0.17%
2,393,453
-590,494
-20% -$124M
AZN icon
116
AstraZeneca
AZN
$249B
$494M 0.17%
3,451,518
-65,576
-2% -$9.65M
HCA icon
117
HCA Healthcare
HCA
$88.8B
$483M 0.17%
1,591,877
+42,883
+3% +$11.9M
VEEV icon
118
Veeva Systems
VEEV
$37B
$481M 0.17%
2,432,413
+486,588
+25% +$88.7M
T icon
119
AT&T
T
$163B
$465M 0.16%
29,158,990
-8,258,254
-22% -$141M
FIS icon
120
Fidelity National Information Services
FIS
$21.8B
$454M 0.16%
8,294,673
+427,504
+5% +$23.5M
ALGN icon
121
Align Technology
ALGN
$12.1B
$447M 0.16%
1,264,074
+80,731
+7% +$25.7M
GWW icon
122
W.W. Grainger
GWW
$60.6B
$446M 0.16%
566,070
-54,726
-9% -$37.7M
TMUS icon
123
T-Mobile US
TMUS
$191B
$444M 0.15%
3,195,743
-81,221
-2% -$11.4M
CSX icon
124
CSX Corp
CSX
$93.7B
$431M 0.15%
12,633,565
-398,745
-3% -$12.6M
CCI icon
125
Crown Castle
CCI
$32.3B
$424M 0.15%
3,720,608
+228,072
+7% +$27.1M

Similar funds

Nuveen's Q2 2023 Portfolio in Review

As of Q2 2023, Nuveen held 3,383 positions worth $287B, up 6.9% from $269B the previous quarter. Its ten largest holdings account for 26% of the portfolio.

Nuveen's Q2 2023 filing shows 280 new, 1,384 increased, 1,249 reduced and 179 closed positions. Its largest new stake was Kenvue: 8,445,273 shares worth $223M. The largest sale was iShares iBoxx $ Investment Grade Corporate Bond ETF, an estimated $1.25B.

By sector, the portfolio is most concentrated in Technology at 28% of assets, up from 26% a quarter earlier, followed by Healthcare and Financials.

  • Nuveen's largest Q2 2023 buy was Kenvue: 8,445,273 shares worth $223M.
  • Nuveen added most to Amazon in Q2 2023, an estimated $672M increase.
  • Nuveen's biggest Q2 2023 reduction was iShares iBoxx $ Investment Grade Corporate Bond ETF, cutting an estimated $1.25B.
  • Nuveen fully exited Qualtrics International Inc. Class A Common Stock in Q2 2023, selling an estimated $130M.
  • Nuveen's ten largest holdings make up 26% of its $287B portfolio in Q2 2023.
  • Nuveen opened 280 new positions and closed 179 in Q2 2023.
  • Nuveen's portfolio value rose 6.9% quarter-over-quarter to $287B.

Based on Nuveen's 13F filing for Q2 2023, filed 14 Aug 2023.